200,000+ products from a single source!
sales@angenechem.com
3262-64-4 | (R)-2-Amino-3-(2-propynylthio)propanoic Acid
CAS No: 3262-64-4 Catalog No: AG003C8T MDL No:MFCD06809960
Product Description
Catalog Number:
AG003C8T
Chemical Name:
(R)-2-Amino-3-(2-propynylthio)propanoic Acid
CAS Number:
3262-64-4
Molecular Formula:
C6H9NO2S
Molecular Weight:
159.2062
MDL Number:
MFCD06809960
IUPAC Name:
(2R)-2-amino-3-prop-2-ynylsulfanylpropanoic acid
InChI:
InChI=1S/C6H9NO2S/c1-2-3-10-4-5(7)6(8)9/h1,5H,3-4,7H2,(H,8,9)/t5-/m0/s1
InChI Key:
JAKVEOCMEMGHGB-YFKPBYRVSA-N
SMILES:
N[C@H](C(=O)O)CSCC#C
Properties
Complexity:
160
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Exact Mass:
159.035g/mol
Formal Charge:
0
Heavy Atom Count:
10
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
159.203g/mol
Monoisotopic Mass:
159.035g/mol
Rotatable Bond Count:
4
Topological Polar Surface Area:
88.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-2.6
Literature
| Title | Journal |
|---|---|
| Preclinical assessment of the distribution, metabolism, and excretion of S-propargyl-cysteine, a novel H2S donor, in Sprague-Dawley rats. | Acta pharmacologica Sinica 20120601 |
| S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in endothelial cells. | International journal of cardiology 20120308 |
| Bioavailability and pharmacokinetics of S-propargyl-L-cysteine, a novel cardioprotective agent, after single and multiple doses in Beagle dogs. | Xenobiotica; the fate of foreign compounds in biological systems 20120301 |
| Effects of S-propargyl-cysteine (SPRC) in caerulein-induced acute pancreatitis in mice. | PloS one 20120101 |
| Leonurine-cysteine analog conjugates as a new class of multifunctional anti-myocardial ischemia agent. | European journal of medicinal chemistry 20110901 |
| S-Propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism. | Amino acids 20110601 |
| Determination of S-propargyl-cysteine in rat plasma by mixed-mode reversed-phase and cation-exchange HPLC-MS/MS method and its application to pharmacokinetic studies. | Journal of pharmaceutical and biomedical analysis 20110405 |
| S-propargyl-cysteine (ZYZ-802), a sulphur-containing amino acid, attenuates beta-amyloid-induced cognitive deficits and pro-inflammatory response: involvement of ERK1/2 and NF-κB pathway in rats. | Amino acids 20110201 |
| S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: involvement of TNF signaling and NF-κB pathway in rats. | Brain, behavior, and immunity 20110101 |
| H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? | PloS one 20110101 |
| Synthesis and biological evaluation of novel leonurine-SPRC conjugate as cardioprotective agents. | Bioorganic & medicinal chemistry letters 20101201 |
| Protective effects of cysteine analogues on acute myocardial ischemia: novel modulators of endogenous H(2)S production. | Antioxidants & redox signaling 20100515 |
| S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. | Journal of cardiovascular pharmacology 20090801 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.